We are live on
!
Find out more
AIIC
AJU IB Investment Company Portfolio holdings
AUM
$30.5M
1-Year Est. Return
128.96%
This Fund
S&P 500
This Quarter
Est. Return
-9.1%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
–
Cap. Flow
+$116M
Cap. Flow
% of AUM
112.56%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
8
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACLX
Arcellx
ACLX
|
+$90.5M |
| 2 |
Kymera Therapeutics
KYMR
|
+$20.6M |
| 3 |
Seer Inc
SEER
|
+$1.79M |
| 4 |
Rallybio
RLYB
|
+$790K |
| 5 |
Xilio Therapeutics
XLO
|
+$656K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
LGM
OGC
AC
PL
WVP
VL
CPM
SP
AJU IB Investment Company's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for AJU IB Investment Company, which disclosed 8 positions worth $103M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Arcellx: 1,047,557 shares worth $80.3M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- AJU IB Investment Company's largest Q4 2024 buy was Arcellx: 1,047,557 shares worth $80.3M.
- AJU IB Investment Company's ten largest holdings make up 100% of its $103M portfolio in Q4 2024.
- AJU IB Investment Company disclosed 8 positions in Q4 2024, its first 13F filing on record.
Based on AJU IB Investment Company's 13F filing for Q4 2024, filed 8 Apr 2025.